What the latest setbacks mean for the story and rating beyond the flesh

Beyond Meat’s latest research update leaves its value estimate largely unchanged at about $1.61 per share, even as analysts grow more cautious about the stock’s long-term narrative. The modest reduction in the assumed discount rate from around 9.38% to around 8.30% reflects a slightly lower perceived risk profile, but not enough to counter concerns about weak demand, competitive pressures and dilution from recent capital movements. As these shifting assumptions reshape how investors frame the Beyond Meat story, stay tuned to see how you can track and interpret future shifts in the narrative.

Stay informed as the fair value of Beyond Meat changes by adding it to your watchlist or portfolio. Alternatively, explore our community to discover new insights on Beyond Meat.

🐂 Optimistic recommendations

  • Recent notes from TD Cowen, Barclays and Argus provide limited, obviously bullish commentary on Beyond Meat, focusing mostly on risk management moves such as a large reduction in debt principal through the exchange of convertible notes, which removes a key balance sheet overlay, but at the cost of substantial dilution.

🐻 Bearish Takeaways

  • TD Cowen analyst Robert Moskow cut his price target to $0.80 from $2 and reiterated a sell rating, pointing to a 413% increase in the number of convertible shares as a major source of dilution that severely limits the upside for existing shareholders and weighs on the valuation.

  • Barclays analyst Benjamin Theurer lowered his target to $1 from $2 and kept an Underweight rating after what he called another quarter of declines and a subdued outlook, citing persistent weak category demand for plant-based meats as a structural challenge to the growth narrative.

  • Argus downgraded Beyond Meat to Sell from Hold, citing rising costs, lower volumes and negative changes in consumer perception of the brand’s health profile, with management’s cost-cutting and product rationalization efforts so far seen as insufficient to restore margins or reignite sustainable growth.

  • Within these firms, analysts point out that execution remains constrained by competitive pressure, weak demand and profitability headwinds. Aggressive price target cuts to the sub-$1 range underscore skepticism that current strategies can sustain higher fair value or multiple expansion in the near term.

Do your thoughts align with Bull or Bear analysts? Maybe you think there’s more to the story. Head over to the Simply Wall St community to discover more insights or start writing your own narrative!

Leave a Comment